Photodynamic therapy (PDT) is an investigational strategy for cancer therapy. It consists of the administration of an exogenous photoactivatable compound that accumulates in malignant and other tissues, followed by an adequate dose of photoactivating light. Photofrin, a mixture of porphyrins, is the photosensitiser that has been used in the majority of clinical trials (Dougherty, 1987; Marcus, 1992) . However, prolonged skin photosensitivity due to non-specific localisation of the photosensitiser is associated with Photofrinmediated PDT (Benson, 1988) . Therefore new photosensitisers and better methods of photosensitiser localisation are being investigated (Bachor et al., 1991; Goff et al., 1991; Gomer, 1991; Pandey et al., 1991; Hasan, 1992; Henderson & Dougherty, 1992) . Other approaches for achieving better localisation include local administration of the photosensitiser (Amano et al., 1988; Bachor et al., 1992) . Recently, there has been considerable interest in a different approach to PDT in which a precursor, ALA, is administered and synthesis of the photosensitiser, PpIX, accomplished in situ (Pottier et al., 1986; Malik & Lugaci, 1987; Malik et al., 1989; Divaris et al., 1990; Kennedy et al., 1990; Bedwell et al., 1992; Kennedy & Pottier, 1992; Loh et al., 1992 Loh et al., , 1993a Rebeiz et al., 1992) . The synthesis of ALA is the rate-limiting step in non-erythroid cells in the pathway of haem biosynthesis (Martin, 1985) (Rebeiz et al., 1992) . PpIX accumulation was also increased in a metastatic variant of Eab lymphoma cells compared with its non-metastatic counterpart (Malik et al., 1989) , although proliferation rates were not explicitly stated. However, except for these two suggestive studies, a correlation of PpIX synthesis with proliferation rates has not yet been investigated systematically in diverse cell lines. Such a study might help clarify the underlying reasons for the increased PpIX concentrations in tumours and have implications in optiising its therapeutic effects. The goals of this study were 3-fold. MIT assay A modified MTT assay adopted from Mosmann (1983) was used. Briefly, after removing the medium, cells were washed once with PBS followed by addition of 1 ml of 1.5 mgml-' MTT dissolved in PBS and were incubated at 37C for 4 h. The MTT solution was carefully removed and 0.5 ml dimethylsulphoxide was added to the cells. Plates were shaken at moderate speed (Clinical Rotator, Fisher) for 30 min to completely dissolve the formazan which was metabolically synthesised from MTT in the mitochondria of living cells. Fifty microlitres of the solution was transferred into a 96-well plate and the plate was read on a ELISA reader (model 2550, Bio-RAD) using a 577 nm bandpass filter. Absorbance of the solution from the treated cell plate was divided by absorbance of the solution from the control cell plate (no treatment) to calculate the fraction of survival.
Modulation of PpIX biosynthesis and PDT NBT-II cells were incubated with ALA alone or ALA plus desferal for 4 and 24 h followed by 1 J cm-2 of 514.5 nm irradiation. For 4 h incubation, drugs were added 48 h after plating cells, and for the 24 h incubation drugs were added 24 h after plating cells so as to obtain comparable cell numbers in both settings at the time of irradiation. Twentyfour hours after PDT, phototoxicity was measured by the MTT assay as above.
Electron microscopy PAM cells were used for this experiment. (Figure 7a and b) . The cell membrane and other subcellular organs showed little damage compared with mitochondria. At the same light dose (3 J cm-2) 20 h following PDT, there was extensive cell necrosis, and total destruction of cell organelles was noted.
Discussion
ALA photobiology has been extensively investigated in plant systems (Rebeiz et al., 1992) . More recently, an exciting avenue of ALA photobiology has opened up with its application to PDT as initiated by Kennedy et al. (Pottier et al., 1986; Malik & Lugaci, 1987; Malik et al., 1989; Divaris et al., 1990; Kennedy et al., 1990; Bedwell et al., 1992; Loh et al., 1992; Kennedy & Pottier, 1992; Loh et al., 1993a,b Fluence (J cm-2)
Fugwe 6 Light dose-dependent phototoxicity mediated by ALAinduced PpIX in different cell lines. Cells were incubated with I mM ALA for 4 h followed by irradiation at a wavelength of 514.5 nm. Phototoxicity was evaluated 24 h after irradiation by the MTT assay as described. (Hillegersberg et al., 1992) (West et al., 1990) . However, the rate of loss of porphyrins did show a slight dependence on cell cycle phase in the same epithelial cells (Fukuda et al., 1993) . Desferal is an iron chelator which blocks ferrochelatase that converts PpIX into haem. Co-administration of 5 ;g ml-' desferal and ALA significantly increased PpIX accumulation in all carcinoma cell lines but not in normal cell lines. Several reports showed that ferrochelatase activity of hepatoma tissue was lower than that of normal liver tissue (Smith, 1987; Hillegersberg et al., 1992) . It is likely that 5 lg ml1' desferal was enough to increase PpIX accumulation in malignant cell lines via decreasing ferrochelatase activity to a negligible level. In the normal cell lines, on the other hand, there was little effect of desferal because of relatively high ferrochelatase activity. The marked dark toxicity seen at 10 g ml-' desferal in cancer cell lines was probably because at this concentration desferal blocked ferrochelatase activity completely and the cells died from a lack of vital enzymes such as the cytochromes. Desferal is a well-known therapeutic drug for acute iron poisoning (Curry, 1992) . Therefore, a combination of ALA and desferal is clinically applicable but clearly a judicious drug dose is mandatory because of its dark toxicity.
The efflux experiments showed two distinct groups in terms of the efflux rate. PpIX efflux is based on both diffusion and interaction with proteins in the culture medium (Granick et al., 1975; Fukuda et al., 1993) . The difference in the rate of efflux observed in this study cannot be explained simply by diffusion from the cells. The cells which produced more PpIX (NBT-II and EJ) seemed to have additional efflux mechanisms because, in these two cell lines, PpIX efflux was rapid. This could also be a reflection of the origin of the cells; malignant cells derived from the urothelium may have a (Ling, 1992) . These compounds have also been suggested to be capable of reversing porphyrin efflux (H. Diddens, personal communication). In our study, verapamil did not block PpIX efflux, suggesting that there might be other mechanisms responsible for PpIX efflux in bladder carcinoma cells. The absence of P-glycoprotein mRNA was confirmed by Northern blot analysis using mdrl probe (data not shown).
PpIX is, of course, synthesised in the mitochondria . We investigated the intracellular localisation of ALA-induced PpIX by using fluorescence microscopy since PpIX synthesis and efflux are dynamic and we did not know which cellular compartment may be dominated by PpIX at the time of irradiation. Although some fluorescence was present in the cytoplasm and plasma membrane, fluorescence microscopy results suggest that most of the ALAinduced PpIX did indeed localise in the mitochondria. Furthermore, electron microscopy results confirmed early irreversible damage of the mitochondria with no obvious damage to other suborganelles (e.g. lysosomes, Golgi) after PDT, suggesting that the primary cause of cell death was mitochondrial phototoxicity, as expected. These observations do not rule out the possibility of more subtle damage (primarily or secondarily) to other organelles.
There was no strict correlation between PpIX cellular content and ALA-induced phototoxicity in different cell lines (Table I and Figure 6 ). There seemed to be two groups in terms of PDT efficacy; four different cell lines which synthesised less than 140ng of PpIXper jig of protein (4h ALA incubation) exhibited very little phototoxic damage, which suggests that some threshold of cellular PpIX is required for PDT-induced cell killing. There was no correlation between cellular PpIX content and phototoxicity in the other cell lines which synthesised relatively large amounts of PpIX (NBT-H1, EJ and PAM) We used 514.5 nm irradiation for PDT because of the similar absorbance at 514 nm and 630 nm in the absorption spectrum of the cell suspension (Figure 1) . Although red light is usually used to excite porphyrins because of its deeper penetration into the tissue, recently attention has been directed to the use of green light in appropriate situations (Bellnier et al., 1985) . Carcinoma in situ of the bladder is the main indication for PDT in clinical urological situations, and 514.5 nm light may be enough to penetrate into the urothelium, so that phototoxic damage of deeper layers such as the muscle layer may be minimised by using 514.5 nm light. Bellnier et al. (1985) reported that Photofrin plus 514.5 mm argon laser light is an effective treatment for small or superficial malignant lesion of urinary bladder. However, absorption by blood might present a problem with 514.5 nm light and still needs to be dealt with.
In summary, this study suggests that a number of cell and tissue characteristics will determine the effectiveness of PDT mediated by ALA-induced PpIX. Most of the in vivo data on ALA-induced PpIX-related PDT utilise experimental tumours, which are fast-growing and typically respond more dramatically to treatment. Clinically, tumours are often heterogeneous in cell type and contain regions varying widely in oxygenation and proliferation rate. As shown here, this heterogeneity of tumours will have serious implications for the uniformity and efficacy of PpIX synthesis and PDT response. Therefore, other careful investigations in vitro as well as in vivo are needed before the initial excitement regarding the use of ALA in PDT is validated.
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